Indications & Usage
Directions: FOR RECTAL USE ONLY.
Bambusa Argentum
FDA Label NDC 48951-2135
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Uriel Pharmacy Inc. for the product Bambusa Argentum (NDC 48951-2135). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding indications & usage, dosage & administration, otc - active ingredient, inactive ingredient, otc - purpose, otc - keep out of reach of children, warnings, otc - questions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Dosage & Administration
Insert 1 suppository as needed.
Otc - Active Ingredient
Active Ingredients: Viscum Mali 4X, Bambusa e nodo 8X, Betonica ex herba 8X, Rosmarinus ex herba 8X, Formica ex animale 9X, Disci intervert. 10X, Jasper 19X, Argentum met. 22X, Arnica e pl. tota 22X
Inactive Ingredient
Inactive Ingredients: Cocoa butter, Sorbitan monolaurate, Micronized silica gel
Otc - Purpose
Use: Temporary relief of headache.
Otc - Keep Out Of Reach Of Children
KEEP OUT OF REACH OF CHILDREN.
Warnings
KEEP REFRIGERATED OR STORE IN
COOL, DRY PLACE. REFRIGERATE TO RESOLIDIFY.
Warnings: Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Do not use if allergic to any ingredient. Consult a doctor before use for serious conditions or if conditions worsen or persist. If pregnant or nursing, consult a doctor before use. Do not use if safety seals on box are broken or missing.
Otc - Questions
Questions? Call 866.642.2858
Uriel, East Troy, WI 53120
www.urielpharmacy.com
* Please review the disclaimer below.
